Provectus Biopharmaceuticals, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of PVCT for the last quarter is 254.99 k USD, and it's 7.11% higher compared to the previous quarter. The net income of Q2 24 is -846.85 k USD.